Provided by Tiger Trade Technology Pte. Ltd.

WUXI XDC

62.800
-1.650-2.56%
Volume:6.45M
Turnover:404.43M
Market Cap:79.00B
PE:62.68
High:64.400
Open:64.300
Low:62.000
Close:64.450
52wk High:85.500
52wk Low:24.700
Shares:1.26B
HK Float Shares:1.26B
Volume Ratio:1.91
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.002
ROE:19.76%
ROA:9.04%
PB:9.46
PE(LYR):62.68
PS:13.83

Loading ...

HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 21%, Sirnaomics up 11%

Tiger Newspress
·
Dec 09, 2025

BOCOM INTL: China's 1st-8th Batch National Drug Procurement Renewal Rules Likely Moderate, Short-Term Catalysts Ample

Stock News
·
Dec 05, 2025

WuXi XDC Cayman Inc.'s (HKG:2268) Stock Has Fared Decently: Is the Market Following Strong Financials?

Simply Wall St.
·
Dec 05, 2025

WuXi XDC (02268) Announces November 2025 Equity Movements

Bulletin Express
·
Dec 04, 2025

HK Movers | Biotech Stocks Rise. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up About 4%

Tiger Newspress
·
Dec 04, 2025

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Stock News
·
Dec 03, 2025

HK Movers | Biotech Stocks Fall. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.

Tiger Newspress
·
Dec 03, 2025

Wuxi XDC Cayman Inc. Files HKEX Disclosure on 3,000 New Shares Issued at HKD 7.501 Each

Reuters
·
Dec 01, 2025

WUXI XDC (02268) Issues 1.1133 Million Shares Due to Option Exercise

Stock News
·
Dec 01, 2025

WuXi XDC (02268) Announces Next Day Disclosure Return, Issued Shares Reach 1,255,074,593

Bulletin Express
·
Dec 01, 2025

HK Pharma Shares Gained. CSPC Pharma Up 7%; 3SBio Up 6%; Remegen Up 4%; Sino Biopharm, Junshi Bio And Hengrui Pharma Up 3%

Tiger Newspress
·
Nov 26, 2025

WuXi XDC (2268) Announces Extraordinary General Meeting and Revised Service Agreements

Bulletin Express
·
Nov 26, 2025

WuXi XDC Cayman Inc. (Stock Code: 2268) Issues Supplemental Announcement on Continuing Connected Transactions

Bulletin Express
·
Nov 25, 2025

HK Movers|Biotech Shares Gained. 3SBio And Hengrui Pharma Up 5%; Tigermed Up 3%; SKB Bio, JW Therap, Remegen And Wuxi XDC Up 2%

Tiger Newspress
·
Nov 24, 2025

Gf Securities: Domestic R&D Investment Demand Recovery Highlights Left-Side Opportunities in Pharma Sector

Stock News
·
Nov 20, 2025

CCB International Raises WUXI XDC (02268) Target Price to HK$90, Keeps "Outperform" Rating

Stock News
·
Nov 20, 2025

Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast

Stock News
·
Nov 18, 2025

Hong Kong Stocks Movement | WUXI XDC (02268) Rises Over 5% Before Noon as Overseas Innovative Drug Deals Expand and Order Momentum Remains Strong

Stock News
·
Nov 13, 2025

CMB International: CXO Sector Performance May Recover in H2, Favors SINO BIOPHARM and WUXI XDC

Deep News
·
Nov 11, 2025

CMB International: Healthcare Sector Favors Stable Strategies, Opportunities in Undervalued Stocks

Stock News
·
Nov 10, 2025